AbbVie's blockbuster-to-be Parkinson's combo hits a wall as FDA questions delivery pump

[Farooqji]

In what’s expected to be one of AbbVie’s “biggest new product launches” in the coming years, the company has hit a snag with its regulatory efforts.

fiercepharma.com/pharma/abb...

[Farooqji]

US FDA declines to approve AbbVie's Parkinson's diseasetherapy

m.investing.com/news/stock-...

[Farooqji in reply to Farooqji]

The FDA has issued a complete response letter for Abbvie's infusion therapy for Parkinsons, citing a need for more information on the device used to administer the treatment

endpts.com/fda-rejects-abbv...

[Juliegrace]

Hopefully Abbvie’s resubmission will satisfy the FDA.

[PalmSprings]

It appears that there is a big pharma company paying someone (or more than one) in the FDA to postpone approval until their product is marketable. Manipulation for market share is rampant. This is my humble opinion.